{"instance_id": "ws_en_019", "response": "```markdown\n| Company Name           | Listing Board        | Bloomberg ticker | Listing Date       | Initial Offering Price(per share) | Total Funds Raised in 2024(million) | Revenue in 2024(million) | Net Income Attributable to Shareholders(million) | R&D Expenses(million) |\n|------------------------|----------------------|------------------|--------------------|----------------------------------|--------------------------------------|--------------------------|------------------------------------------------|-----------------------|\n| CG Oncology            | Nasdaq Global Select  | CGON             | 2024/01/25         | 19.00                            | 163.2                               | N/A                      | N/A                                            | N/A                   |\n| Zenas BioPharma        | Nasdaq Global Select  | ZBIO             | 2024/09/13         | 16.00                            | 225.0                               | N/A                      | N/A                                            | N/A                   |\n| Upstream Bio           | Nasdaq Global Select  | UPB              | 2024/10/11         | 17.00                            | 293.0                               | 2.79                     | -21.2                                          | 26.3                  |\n| MBX Biosciences        | Nasdaq Global Select  | MBX              | 2024/09/13         | 19.00                            | 160.0                               | N/A                      | -15.6                                          | 26.3                  |\n| Metagenomi             | Nasdaq Global Select  | MGX              | 2024/02/09         | 19.00                            | 163.2                               | -26.3                    | -109.2                                         | 28.3                  |\n```"}
